Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
16.76
-0.36 (-2.10%)
Oct 31, 2024, 4:00 PM EDT - Market closed
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $431.12 million as of October 31, 2024.
Market Cap
431.12M
Enterprise Value
213.07M
1-Year Change
n/a
Ranking
Category
Stock Price
Market Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has increased from $402.09M to $431.12M, an increase of 7.22%. That is a compound annual growth rate of 13.01%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 30, 2024 | 440.40M | 9.53% |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Talkspace | 452.49M |
Biomea Fusion | 449.37M |
Foghorn Therapeutics | 448.72M |
4D Molecular Therapeutics | 445.38M |
National Research | 440.65M |
COMPASS Pathways | 434.95M |
Theravance Biopharma | 429.05M |
Sangamo Therapeutics | 424.77M |